165 related articles for article (PubMed ID: 20805703)
1. [A case of central nervous system myelomatosis with complex chromosome aberrations].
Bang HI; Yoo JY; Kim KH; Park R; Shin JW; Choi TY; Lee SC; Park HS; Won JH
Korean J Lab Med; 2010 Aug; 30(4):334-8. PubMed ID: 20805703
[TBL] [Abstract][Full Text] [Related]
2. Multiple myeloma involving central nervous system: high frequency of chromosome 17p13.1 (p53) deletions.
Chang H; Sloan S; Li D; Keith Stewart A
Br J Haematol; 2004 Nov; 127(3):280-4. PubMed ID: 15491286
[TBL] [Abstract][Full Text] [Related]
3. Patterns of central nervous system involvement in relapsed and refractory multiple myeloma.
Abdallah AO; Atrash S; Shahid Z; Jameel M; Grazziutti M; Apewokin S; Kumar NS; Restrepo A; Waheed S; Van Rhee F; Heuck CJ; Johann D; Barlogie B; Usmani SZ
Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):211-4. PubMed ID: 24373936
[TBL] [Abstract][Full Text] [Related]
4. Abnormal cytogenetics predict poor survival after high-dose therapy and autologous blood cell transplantation in multiple myeloma.
Rajkumar S; Fonseca R; Lacy M; Witzig T; Lust J; Greipp P; Therneau T; Kyle R; Litzow M; Gertz M
Bone Marrow Transplant; 1999 Sep; 24(5):497-503. PubMed ID: 10482933
[TBL] [Abstract][Full Text] [Related]
5. Central nervous system multiple myeloma--potential roles for intrathecal therapy and measurement of cerebrospinal fluid light chains.
Lee D; Kalff A; Low M; Gangatharan S; Ho P; Bajel A; Ritchie D; Grigg A; Spencer A
Br J Haematol; 2013 Aug; 162(3):371-5. PubMed ID: 23718539
[TBL] [Abstract][Full Text] [Related]
6. Genetic risk identifies multiple myeloma patients who do not benefit from autologous stem cell transplantation.
Chang H; Qi XY; Samiee S; Yi QL; Chen C; Trudel S; Mikhael J; Reece D; Stewart AK
Bone Marrow Transplant; 2005 Nov; 36(9):793-6. PubMed ID: 16113669
[TBL] [Abstract][Full Text] [Related]
7. Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations.
Fassas AB; Muwalla F; Berryman T; Benramdane R; Joseph L; Anaissie E; Sethi R; Desikan R; Siegel D; Badros A; Toor A; Zangari M; Morris C; Angtuaco E; Mathew S; Wilson C; Hough A; Harik S; Barlogie B; Tricot G
Br J Haematol; 2002 Apr; 117(1):103-8. PubMed ID: 11918539
[TBL] [Abstract][Full Text] [Related]
8. [IgG-lambda-type multiple myeloma with plasma-cell pericardial effusion and terminal plasma-cell leukemia].
Klug S; Höltermann F; Fritsch H
Dtsch Med Wochenschr; 1992 Jun; 117(23):900-4. PubMed ID: 1597118
[TBL] [Abstract][Full Text] [Related]
9. Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantation.
Neben K; Jauch A; Bertsch U; Heiss C; Hielscher T; Seckinger A; Mors T; Müller NZ; Hillengass J; Raab MS; Ho AD; Hose D; Goldschmidt H
Haematologica; 2010 Jul; 95(7):1150-7. PubMed ID: 20220069
[TBL] [Abstract][Full Text] [Related]
10. [A case of aggressive myeloma with abnormal plasmocytes in pleural effusion and cerebrospinal fluid].
Sekikawa T; Iwase S; Kawano T; Takahara S; Ito K; Yamada J; Yamazaki Y; Yamada H
Rinsho Ketsueki; 1999 Jan; 40(1):22-7. PubMed ID: 10067092
[TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics and Prognosis of MAF Deletion in Chinese Patients With Multiple Myeloma.
Wang Y; Li Q; Xing S; Zhang H; Li D
Clin Lymphoma Myeloma Leuk; 2019 Sep; 19(9):e545-e550. PubMed ID: 31262667
[TBL] [Abstract][Full Text] [Related]
12. Chromosome 13q deletion and IgH abnormalities may be both masked by near-tetraploidy in a high proportion of multiple myeloma patients: a combined morphology and I-FISH analysis.
Koren-Michowitz M; Hardan I; Berghoff J; Yshoev G; Amariglio N; Rechavi G; Nagler A; Trakhtenbrot L
Cancer Lett; 2007 Oct; 255(2):307-14. PubMed ID: 17590504
[TBL] [Abstract][Full Text] [Related]
13. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
[TBL] [Abstract][Full Text] [Related]
14. [Study on molecular cytogenetic abnormalities in multiple myeloma].
Liu SY; Li JY; Chen LJ; Huang JW; Pan JL; Qiu HR; Shen YF; Xu W; Xue YQ
Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):223-6. PubMed ID: 17877196
[TBL] [Abstract][Full Text] [Related]
15. Aggressive neoplastic plasma cell growth with MLL gene rearrangement after high-dose therapy with autologous stem cell support for multiple myeloma.
Nishii K; Katayama N; Chen F; Usui E; Kadowaki S; Mitani H; Masuya M; Kageyama SI; Kita K; Shiku H
Bone Marrow Transplant; 2001 Mar; 27(5):555-8. PubMed ID: 11313693
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of a cytogenetically complex Chinese multiple myeloma-derived cell line with homozygous p53 deletion and cyclin E overexpression.
Cheng SH; Ng MH; Tsang KS; Lau KM; Chan JC; Liu HS; Chu RW; Poon CS; Ng HK
Int J Oncol; 2004 May; 24(5):1141-8. PubMed ID: 15067335
[TBL] [Abstract][Full Text] [Related]
17. [Fluorescence in situ hybridization identifies complex chromosomal aberrations in multiple myeloma].
Liu SY; Huang JW; Zhang J; Du HP; Jiang H; Li JY; Xue YQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):685-8. PubMed ID: 18067084
[TBL] [Abstract][Full Text] [Related]
18. p53 gene deletion detected by fluorescence in situ hybridization is an adverse prognostic factor for patients with multiple myeloma following autologous stem cell transplantation.
Chang H; Qi C; Yi QL; Reece D; Stewart AK
Blood; 2005 Jan; 105(1):358-60. PubMed ID: 15339849
[TBL] [Abstract][Full Text] [Related]
19. Increased copy number of the interleukin-6 receptor gene is associated with adverse survival in multiple myeloma patients treated with autologous stem cell transplantation.
Kim SY; Min HJ; Park HK; Oh B; Kim TY; She CJ; Hwang SM; Kim M; Kim HK; Kim I; Yoon SS; Park S; Kim BK; Lee JH; Lee DS;
Biol Blood Marrow Transplant; 2011 Jun; 17(6):810-20. PubMed ID: 21220034
[TBL] [Abstract][Full Text] [Related]
20. Multiple myeloma invasion of the central nervous system.
Marjanović S; Mijusković Z; Stamatović D; Madjaru L; Ralić T; Trimcev J; Stojanović J; Radović V
Vojnosanit Pregl; 2012 Feb; 69(2):209-13. PubMed ID: 22500379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
